Eameema Muntimadugu

Dr. Eameema Muntimadugu

University of Maryland, College Park, College Park, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
EMEameema Muntimadugu
Eameema Muntimadugu
RDRaju Dhommati
Raju Dhommati
AJAnjali Jain
Anjali Jain
VCVenu Gopala Swami Challa
Venu Gopala Swami Challa
MSM. Shaheen
M. Shaheen
WKwahid khan
wahid khan

1 July 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
EMEameema Muntimadugu
Eameema Muntimadugu
RKRajendra Kumar
Rajendra Kumar
SSShantikumar Saladi
Shantikumar Saladi
TRTowseef Amin Rafeeqi
Towseef Amin Rafeeqi
WKwahid khan
wahid khan

2 June 2015 in Drug Delivery
Verified
Journal Article
Closed access
SKSameer S. Katiyar
Sameer S. Katiyar
EMEameema Muntimadugu
Eameema Muntimadugu
TRTowseef Amin Rafeeqi
Towseef Amin Rafeeqi
Avi J. DombAvi J. Domb
Avi J. Domb
WKwahid khan
wahid khan
P-glycoprotein (P-gp) efflux is the major cause of multidrug resistance (MDR) in tumors when using anticancer drugs, moreover, poor bioavailability of few drugs is also due to P-gp efflux in the gut. Rapamycin (RPM) is in the clinical trials for breast cancer treatment, but its P-gp substrate property leads to poor oral bioavailability and efficacy. The objective of this study is to formulate and evaluate nanoparticles of RPM, along with a chemosensitizer (piperine, PIP) for improved oral bioavailability and efficacy. Poly(d,l-lactide-co-glycolide) (PLGA) was selected as polymer as it has moderate MDR reversal activity, which may provide additional benefits. The nanoprecipitation method was used to prepare PLGA nanoparticles with particle size below 150 nm, loaded with both drugs (RPM and PIP). Prepared nanoparticles showed sustained in vitro drug release for weeks, with initial release kinetics of zero order with non-Fickian transport, subsequently followed by Higuchi kinetics with Fickian diffusion. An everted gut sac method was used to study the effect of P-gp efflux on drug transport. This reveals that the uptake of the RPM (P-gp substrate) has been increased in the presence of chemosensitizer. Pharmacokinetic studies showed better absorption profile of RPM from polymeric nanoparticles compared to its suspension counterpart and improved bioavailability of 4.8-folds in combination with a chemosensitizer. An in vitro cell line study indicates higher efficacy of nanoparticles compared to free drug solution. Results suggest that the use of a combination of PIP with RPM nanoparticles would be a promising approach in the treatment of breast cancer.

1 December 2017 in Pharmacological Research
Verified
Journal Article
Closed access
EMEameema Muntimadugu
Eameema Muntimadugu
Nagavendra KommineniNagavendra Kommineni
Nagavendra Kommineni
WKwahid khan
wahid khan

24 December 2013
Verified
Book Chapter
Closed access
PDF file
WKWahid Khan
Wahid Khan
EMEameema Muntimadugu
Eameema Muntimadugu
MJMichael Jaffe
Michael Jaffe
Avi J. DombAvi J. Domb
Avi J. Domb

2 October 2013 in Israel Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
EMEameema Muntimadugu
Eameema Muntimadugu
DIDiana E. Ickowicz
Diana E. Ickowicz
Avi J. DombAvi J. Domb
Avi J. Domb
WKwahid khan
wahid khan